View Press Releases
-
CloudLIMS Launches New Instrument Module to Meet ISO/IEC 17025:2017 Requirements
WILMINGTON, US - Jan 17, 2019 - CloudLIMS, a leading laboratory data management informatics provider, announces the release of an Instrument Module for its Laboratory Information Management System (LIMS), CloudLIMS
Jan 16, 2019
-
Key Biologics and Cascade Regional Blood Services Partner on Leukapheresis Collections
TACOMA, WA, UNITED STATES - Jan 16, 2019 - Key Biologics LLC and Cascade Regional Blood Services (CRBS) today announced a multi-year agreement to provide researchers in academia, pharma and biotech with vital blood products and materials for their research and product manufacturing efforts
Jan 15, 2019
-
Niche Biometric CRO launches dedicated pharmacovigilance business
LONDON, UNITED KINGDOM - Jan 15, 2019 - LONDON (UK) - Quanticate, a leading global data-focused clinical research organisation (CRO) has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services
Jan 15, 2019
-
Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Fourth Consecutive Year
PRINCETON, NJ - Jan 15, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or services
Jan 15, 2019
-
Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development
BOURNEMOUTH, UK - Jan 14, 2019 - Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement
Jan 14, 2019
-
Sekisui XenoTech Expands Partnership for Japanese Collection of Research Bioresources Cell Bank (JCRB) Distribution
KANSAS CITY, KS, UNITED STATES - Jan 8, 2019 - After 3 years as the official distributor of JCRB cell lines in North America, Sekisui XenoTech has expanded its agreement with the National Institute of Biomedical Innovation to include distribution to Europe
Jan 8, 2019
-
Creative Diagnostics Introduces Pathology Antibodies for Researchers
SHIRLEY, NY, UNITED STATES - Jan 8, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now is proud to announce that it launches a number of high quality pathology antibodies including Her2, PD-1, Ki-67, Tim3, CTLA4, Lp-PLA2, Muc2, Cytokeratin 18, BRAF V600E, IDH1 R132H, MLH1, MSH2, MSH6, and PMS2
Jan 7, 2019
-
Creative Proteomics Upgrades Four Proteomics Services for Protein Related Projects
SHIRLEY, NY - Jan 5, 2019 - Creative Proteomics, a leading supplier in drug development services, recently announces that they have upgraded four services related to protein research projects
Jan 3, 2019
-
Certara Publishes New Report Investigating Success Factors for Outcomes-based Contracting, Giving Guidelines to Pharma and Payers
PRINCETON, NJ - Dec 19, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced a new research report that investigates the potential of pharmaceutical outcomes-based contracting
Dec 19, 2018
-
CD Genomics Claims a Discount for Most Services to Celebrate Christmas&New Year
SHIRLEY, NY - Dec 19, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of Christmas and New Year promotion from December 1st to January 31st
Dec 18, 2018
-
Vyasa Analytics Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
BOSTON, MA - Dec 18, 2018 - Vyasa Analytics, a provider of scalable, deep-learning software and analytics for life sciences and healthcare organizations, today announced they have joined Accentures partner ecosystem, designed to help independent software vendors (ISVs) and life science companies work more effectively to accelerate drug discovery efforts and improve patient outcomes
Dec 18, 2018
-
Creative Biolabs Announced the Monoclonal Antibody Screening Technology for Research Use
SHIRLEY, NY - Dec 18, 2018 - December 18, 2018, Creative Biolabs, one of world-leading suppliers and manufacturers from USA, announced a technique about the monoclonal antibody screening for research use
Dec 17, 2018
-
Linguamatics Highlights 2018 Achievements and Advances NLP Text Analytics Market Leadership
CAMBRIDGE, N/A, UNITED KINGDOM - Dec 12, 2018 - In 2018, Linguamatics advanced its position as the market-leading provider of natural language processing (NLP) text analytics for healthcare and the life sciences, winning prestigious industry awards, introducing innovative product enhancements, and partnering with organizations to extend the value of Linguamatics solutions
Dec 12, 2018
-
OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD
STOCKHOLM, SWEDEN - Dec 12, 2018 - Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market
Dec 12, 2018
-
Creative Diagnostics Introduces Cytotoxic Drug Antibodies for Science Community
SHIRLEY, NY, UNITED STATES - Dec 13, 2018 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics is proud to announce that it has launched a new set of antibodies specific to cytotoxic drugs for life science community facing the growing challenges for scientific research
Dec 11, 2018
-
Rho Announces New Regulatory Strategy and Submissions Business Segment
CHAPEL HILL, NC, UNITED STATES - Dec 10, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced a new Regulatory Strategy and Submissions business segment
Dec 11, 2018
-
FairJourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery with Geneious Biologics
AUCKLAND CITY, NEW ZEALAND - Dec 10, 2018 - AUCKLAND, NZ – December 10, 2018 – Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the companys growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programs
Dec 10, 2018
-
Qlucore announces partnership with Cambridge Protein Arrays Ltd
GUILDFORD, UNITED KINGDOM - Dec 10, 2018 - The partnership announced today between Qlucore and Cambridge Protein Arrays Ltd (CPA) will strengthen the end-to-end solution for protein analysis
Dec 10, 2018
-
HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for Cancer
CAMBRIDGE, MA, UNITED STATES - Dec 10, 2018 - HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, today announced the formation of Victa Biotherapeutics, a joint venture with Vikas P
Dec 10, 2018
-
10x Genomics Acquires Spatial Transcriptomics
PLEASANTON, CA, UNITED STATES - Dec 10, 2018 - 10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics
Dec 10, 2018